To the Editor: In their study comparing controlled delivery of high humidity, low humidity, and mist therapy for croup in emergency departments, Dr Scolnik and colleagues1 demonstrated that mist therapy does not lead to an improvement in croup scores. Their study also suggests that a reexamination of the use of aerosolized epinephrine in mild croup is warranted.
Aerosolized epinephrine use for croup in the emergency department has generally been reserved for moderate to severe disease for 2 reasons. First, mild disease has been believed to respond to cool mist so that aerosolized epinephrine is not necessary.2 Second, all patients who get aerosolized epinephrine are believed to require several hours of observation in the emergency department prior to discharge.3
Scolnik et al cast considerable doubt on the first reason. The second, however, is dubious as well. The effect of aerosolized epinephrine is temporary, and there is some possibility of the patient returning to the pretreatment status when the effect wears off in 1 to 2 hours. However, there is evidence against the concept of aerosolized epinephrine causing a rebound effect, with worsening of illness beyond the pretreatment status.2 - 4 The studies of aerosolized epinephrine have generally excluded patients with mild disease so that many of the included patients are ill enough that a return to their pretreatment status would make them unsuitable for discharge. This has led to the persistence of the recommendation for a 2- or 3-hour observation period.5
However, this logic does not extend to patients whose initial presentation is mild, for whom a return to pretreatment status would not represent an undue risk. Some of these patients have enough discomfort from a croupy cough or mild stridor with exertion that intervention is justified—the intent of giving cool mist. Because cool mist is no better than placebo and because aerosolized epinephrine is effective, it seems reasonable to administer aerosolized epinephrine and steroids and discharge these patients without the burden of a 2- to 3-hour observation period.
Financial Disclosures: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.